Cargando…
Lanthanum carbonate: safety data after 10 years
Despite 10 years of post‐marketing safety monitoring of the phosphate binder lanthanum carbonate, concerns about aluminium‐like accumulation and toxicity persist. Here, we present a concise overview of the safety profile of lanthanum carbonate and interim results from a 5‐year observational database...
Autores principales: | Hutchison, Alastair J, Wilson, Rosamund J, Garafola, Svetlana, Copley, John Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129531/ https://www.ncbi.nlm.nih.gov/pubmed/27479781 http://dx.doi.org/10.1111/nep.12864 |
Ejemplares similares
-
Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients
por: Hutchison, Alastair J, et al.
Publicado: (2013) -
Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate
por: Mohammed, Ismail A, et al.
Publicado: (2008) -
Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden
por: Hutchison, Alastair J., et al.
Publicado: (2008) -
Elemental calcium intake associated with calcium acetate/calcium carbonate in the treatment of hyperphosphatemia
por: Wilson, Rosamund J, et al.
Publicado: (2017) -
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
por: Garafola, Svetlana, et al.
Publicado: (2023)